Understanding Fluorescein Angiography
Fluorescein angiography is a specialized imaging test that allows your eye care team to photograph blood flow through the retina, the light-sensitive tissue lining the back of your eye. During the test, a safe yellow dye called fluorescein is injected into a vein in your arm. As the dye travels through your bloodstream and reaches the tiny blood vessels in your eye, a special camera captures detailed photographs of how the dye moves through those vessels. These images give your care team a clear and detailed map of your retinal circulation.
Think of it like adding a bright highlighter to the blood flowing through your eye. The dye lights up under a special blue light, making it possible for the camera to capture the path blood takes as it nourishes your retina. This helps your care team see areas where blood vessels may be leaking, blocked, or growing abnormally. The information gathered from this test plays an important role in diagnosing a wide range of retinal conditions and in planning the most effective course of treatment.
Your retina depends on a healthy network of blood vessels to deliver oxygen and nutrients. When these blood vessels become damaged, blocked, or begin to leak, your vision can be affected in ways that may not be noticeable at first. Many retinal conditions develop gradually, and early changes in blood flow can occur long before you notice any symptoms in your day-to-day vision.
Fluorescein angiography provides your care team with information that cannot be gathered through a standard eye exam alone. While your doctor can see the surface of the retina during a routine examination, this imaging test reveals the dynamic flow of blood through the vessels in real time. It shows not just the structure of those vessels but how well they are actually working. This deeper level of detail is essential for making accurate diagnoses and choosing the right treatment approach.
Fluorescein angiography has been used in ophthalmology for decades and remains one of the most valuable tools available for evaluating retinal health. It is performed in the office setting and does not require a hospital visit or general anesthesia. The test is well tolerated by most patients, and the information it provides often cannot be obtained through any other single test.
Your care team at Washington Eye Institute uses fluorescein angiography as part of a thorough approach to diagnosing and managing retinal conditions. Whether your doctor suspects a new problem or needs to monitor how an existing condition is responding to treatment, this test can provide the detailed answers needed to guide your care with confidence.
Who May Need This Test
Diabetes can damage the small blood vessels in the retina over time, a condition known as diabetic retinopathy. In its early stages, these vessels may begin to leak fluid or develop tiny bulges. In more advanced stages, new and fragile blood vessels may grow on the surface of the retina, a process that can lead to serious vision loss if not detected and treated promptly.
Fluorescein angiography is especially helpful for patients with diabetes because it can reveal these vascular changes with great precision. The images show exactly where vessels are leaking, whether new abnormal vessels have begun to form, and how extensive the damage may be. This information helps your care team decide whether treatment such as laser therapy or injections is needed, and it helps them target that treatment to the areas that need it most.
Age-related macular degeneration affects the central part of the retina called the macula, which is responsible for sharp, detailed vision. The condition comes in two forms. The dry form involves a gradual thinning of the macula, while the wet form involves abnormal blood vessels that grow beneath the retina and leak fluid or blood. The wet form can cause rapid and significant vision loss.
Fluorescein angiography is particularly useful in identifying the wet form of macular degeneration. The test clearly shows where abnormal vessels are growing and leaking, which helps your care team determine the best treatment plan. It can also help distinguish between the dry and wet forms of the disease when the diagnosis is not entirely clear from other tests alone.
Blood vessels in the retina can become blocked or narrowed, similar to how blood vessels in other parts of the body can be affected. Retinal vein occlusion occurs when a vein in the retina becomes blocked, causing blood and fluid to back up and leak into the retinal tissue. Retinal artery occlusion occurs when an artery becomes blocked, cutting off blood supply to part of the retina. Both conditions can cause sudden and sometimes significant changes in vision.
Fluorescein angiography helps your care team see the extent and location of these blockages. The images reveal where blood flow is being disrupted and whether surrounding areas of the retina are being affected. This information is critical for determining how severe the condition is and what treatments may help preserve or restore vision.
Sometimes patients experience changes in their vision, such as blurriness, distortion, or dark spots, that cannot be fully explained by a routine eye exam. In these situations, fluorescein angiography can provide answers by revealing problems in the retinal blood vessels that may not be visible on the surface.
Conditions like central serous chorioretinopathy, which causes fluid to build up under the macula, and retinal vasculitis, which involves inflammation of the retinal blood vessels, can be identified through this test. By pinpointing the source of the problem, your care team can develop a focused and effective treatment plan.
Fluorescein angiography is not only used for initial diagnosis. It is also a valuable tool for monitoring how well a treatment is working over time. For example, if a patient is receiving injections for wet macular degeneration or laser treatment for diabetic retinopathy, repeat angiography can show whether the leaking vessels have responded to treatment and whether new areas of concern have developed.
This ongoing monitoring helps your care team make informed decisions about whether to continue, adjust, or change your treatment plan. It provides objective evidence of how your condition is progressing and ensures that your care remains as effective as possible at every stage.
How Fluorescein Angiography Works
Fluorescein is a bright yellow-orange dye that has a unique property. When exposed to blue light, it glows, or fluoresces, with a vivid green-yellow color. This property makes it an ideal substance for illuminating the blood vessels inside the eye. The dye is not a contrast agent like those used in some other medical imaging tests, and it works through a different mechanism than dyes used for procedures like CT scans or MRIs.
Once the dye is injected into a vein in your arm, it mixes with your blood and travels through your entire circulatory system, including the delicate network of blood vessels in your retina. As the dye passes through these vessels, a specialized camera equipped with filters captures photographs at rapid intervals. The blue light from the camera causes the dye to glow, making the blood vessels stand out brightly against the darker background of the retina.
The fundus camera used during fluorescein angiography is specifically designed to photograph the inside of the eye. It takes a rapid series of images as the dye first enters the retinal arteries, fills the smaller capillaries, and then drains through the retinal veins. This sequence typically unfolds over the course of several seconds and provides a frame-by-frame view of blood flow through the retina.
Early-phase images show the dye entering the retinal arteries and beginning to fill the capillary network. Mid-phase images capture the dye as it spreads throughout the retinal vessels. Late-phase images, taken several minutes after the injection, reveal areas where dye may be leaking out of damaged vessels or pooling in areas where it should not be. Each phase provides different and complementary information about the health of your retinal circulation.
The images produced by fluorescein angiography contain a wealth of information that your retinal specialist carefully reviews. Healthy blood vessels appear as bright, well-defined lines with smooth walls and no leakage. When problems are present, the images may show a variety of patterns that point to specific diagnoses.
Areas of hyperfluorescence, where the dye appears brighter than expected, can indicate leaking vessels, pooling of fluid, or abnormal new vessel growth. Areas of hypofluorescence, where the dye appears darker or absent, may indicate blocked vessels or areas where blood flow has been cut off. By analyzing these patterns across the full series of images, your care team can build a detailed picture of what is happening inside your eye.
You may have heard of another test called optical coherence tomography angiography, often referred to as OCT angiography or OCTA. While both tests evaluate blood flow in the retina, they work in very different ways and provide different types of information. Understanding the distinction can help you appreciate why your care team may recommend one test over the other, or sometimes both.
OCT angiography uses light waves rather than injected dye to create images of retinal blood flow. It is completely noninvasive and does not require an injection. However, fluorescein angiography provides information that OCTA cannot, particularly the ability to show active leakage from blood vessels in real time. Because the fluorescein dye physically moves through the vessels and leaks out of damaged areas, the test captures dynamic information about vascular function that a dye-free scan may miss. For many retinal conditions, especially when leakage is a key concern, fluorescein angiography remains the preferred diagnostic tool.
What the Test Can Reveal
One of the most important findings fluorescein angiography can detect is leakage from retinal blood vessels. Healthy blood vessel walls form a tight barrier that keeps blood and fluid inside the vessel where they belong. When disease damages these vessel walls, fluid, proteins, and sometimes blood can seep out into the surrounding retinal tissue. This leakage can cause swelling, distortion, and loss of vision.
The fluorescein dye makes this leakage visible in a way that no other test can match. On the images, leaking vessels appear as bright areas that grow larger and more diffuse over time as the dye spreads beyond the vessel walls. Your care team can identify exactly which vessels are leaking, how severely they are affected, and how much of the retina is being impacted. This information is essential for conditions like diabetic macular edema, wet macular degeneration, and central serous chorioretinopathy.
Fluorescein angiography can also reveal areas where blood flow has been reduced or completely blocked. When a vessel is obstructed, the dye cannot flow through it, and the corresponding area of the retina appears dark on the images. These areas of poor perfusion, meaning inadequate blood supply, can lead to tissue damage and vision loss if they are extensive.
Identifying blocked vessels is critical in conditions like retinal vein occlusion and retinal artery occlusion. The extent of the blockage often determines the severity of the condition and influences treatment decisions. In diabetic retinopathy, areas of poor perfusion can trigger the growth of abnormal new blood vessels, a dangerous complication that your care team watches for closely.
When the retina is deprived of adequate blood flow, it sometimes responds by growing new blood vessels in an attempt to restore its oxygen supply. Unfortunately, these new vessels, called neovascularization, are fragile and poorly formed. They tend to leak fluid and blood, which can lead to serious complications including scar tissue formation and retinal detachment.
Fluorescein angiography is highly effective at detecting neovascularization. The abnormal vessels light up brightly with the dye and often show extensive leakage even in the early phases of the test. Identifying these vessels early is important because treatment, often in the form of injections or laser therapy, can help stop their growth and prevent further damage to the retina.
Inflammation inside the eye can affect the blood vessels of the retina in ways that may not be visible during a standard exam. Retinal vasculitis, a condition in which the immune system attacks the retinal blood vessels, can cause vessel wall inflammation, leakage, and even blockage. Other inflammatory conditions, including uveitis, can also affect retinal blood flow.
Fluorescein angiography can detect signs of vascular inflammation, such as staining of the vessel walls, leakage along the course of inflamed vessels, and areas of poor perfusion caused by inflammatory damage. These findings help your care team determine the type and severity of the inflammation and choose the most appropriate anti-inflammatory treatment.
In conditions like central serous chorioretinopathy, fluid can accumulate beneath the retina, causing it to lift away from its supporting tissue. This fluid buildup can distort vision and create a blind spot in the central visual field. Fluorescein angiography can pinpoint the exact location where fluid is leaking through the retinal pigment epithelium, the layer beneath the retina, and pooling underneath.
The images typically show a small, bright point of leakage that expands over the course of the test as dye accumulates in the space beneath the retina. Identifying this leak point is important because it guides treatment decisions, including whether observation, medication, or targeted laser treatment is the best approach for resolving the fluid buildup and restoring vision.
What to Expect During Your Visit
There is very little preparation needed before fluorescein angiography. Your care team will ask you about any allergies you have, particularly to dyes or iodine, and will review your medical history. It is helpful to let your team know about all medications you are taking, as well as any previous reactions you may have had to contrast dyes or fluorescein.
You should plan to have someone drive you home after the appointment, as your pupils will be dilated for the test and your vision will be temporarily blurry, especially in bright light. Bringing sunglasses to wear after the appointment can make the drive home more comfortable. You may eat and drink normally before and after the test.
When you arrive for your fluorescein angiography, your care team will begin by placing dilating drops in your eyes. These drops widen your pupils so the camera can get a clear view of your retina. The drops typically take about twenty to thirty minutes to reach full effect, during which time you can relax in the waiting area.
Once your pupils are fully dilated, you will be seated in front of the specialized fundus camera. A small intravenous line will be placed in a vein in your arm or hand, similar to having blood drawn. The fluorescein dye is then injected through this line. You may notice a warm sensation as the dye enters your bloodstream. The photographer will begin taking pictures almost immediately, capturing the dye as it travels to your eyes and flows through your retinal blood vessels. The entire photography session typically takes about ten to twenty minutes.
Fluorescein angiography is generally well tolerated, but there are some common side effects you should be aware of. The most noticeable effect is a temporary change in the color of your skin and urine. The yellow dye can give your skin a slight yellowish tint for several hours, and your urine may appear bright yellow or orange for up to twenty-four to forty-eight hours after the test. This is completely normal and harmless as your body naturally filters the dye through your kidneys.
Some patients experience mild nausea shortly after the dye injection, which usually passes within a few minutes. Rarely, a patient may develop an allergic reaction to the dye, which can range from mild skin hives to more significant symptoms. Your care team is trained to recognize and manage allergic reactions and will monitor you closely during and after the injection. Serious allergic reactions are uncommon, but the care team is prepared to respond promptly if one occurs.
Once the photography is complete, the intravenous line is removed, and you are free to go home. Your pupils will remain dilated for several hours, so your near vision will be blurry and you will be more sensitive to bright light during that time. Most patients find that their vision returns to normal within four to six hours.
Drinking plenty of water after the test can help your body flush the dye from your system more quickly. You can resume all of your normal activities, including taking your regular medications, eating normally, and returning to work the next day. If you experience any unusual symptoms after the test, such as persistent nausea, skin rash, or difficulty breathing, you should contact your care team right away.
Your retinal specialist will review the full set of angiography images carefully, examining each phase of the dye transit for signs of vascular abnormalities. In many cases, preliminary findings can be discussed with you on the same day as the test. A thorough interpretation of the images may take additional time, and your care team will schedule a follow-up visit or call to go over the detailed results with you.
The results of your fluorescein angiography will guide your care team in making important decisions about your treatment. If the images reveal areas of leakage, blockage, or abnormal vessel growth, your doctor will explain what those findings mean for your eye health and discuss the treatment options available to you. If the test shows stable findings, that information is equally valuable, as it confirms that your current management plan is working effectively.
Your Journey at Washington Eye Institute
Scheduling your fluorescein angiography at Washington Eye Institute is straightforward. Our team is available at our Greenbelt, Rockville, and Cumberland locations, making it convenient to find an appointment time and place that works for your schedule. When you call to schedule, our staff will provide any specific instructions for your visit and answer questions you may have about what to expect.
When you arrive for your appointment, you will be checked in and guided to the imaging area. The care team will review your medical history, confirm your allergy status, and explain each step of the process before it begins. We want you to feel informed and comfortable throughout your visit, and our staff is happy to address any concerns at any point during the appointment.
At Washington Eye Institute, your fluorescein angiography is performed by a trained ophthalmic photographer who works closely with your retinal specialist. This team-based approach ensures that the images captured are of the highest quality and that your comfort is prioritized throughout the test. Your retinal specialist reviews every image personally and integrates the findings with your complete medical history and other diagnostic tests.
If treatment is recommended based on your angiography results, your care team will walk you through the options in clear and understandable terms. We believe that informed patients make the best decisions about their own care, and we take the time to ensure you understand your diagnosis, your options, and the expected outcomes of any recommended treatment.
Many retinal conditions require ongoing monitoring over months or years. If your condition calls for repeat fluorescein angiography, your care team will work with you to establish a follow-up schedule that balances thorough monitoring with your convenience. Each test builds on the information gathered from previous visits, allowing your care team to track changes in your retinal circulation over time and adjust your treatment plan as needed.
Between visits, our team is available to answer questions and address concerns. Whether you notice a change in your vision or simply have a question about your condition, we encourage you to reach out. Timely communication between you and your care team is an important part of maintaining your retinal health and achieving the best possible outcomes for your vision.
Frequently Asked Questions About Fluorescein Angiography
The entire appointment for fluorescein angiography typically lasts about one to two hours, which includes time for pupil dilation, the imaging session itself, and a brief observation period afterward. The actual photography portion of the test usually takes about ten to twenty minutes. The dilation drops need about twenty to thirty minutes to take full effect before imaging can begin, which accounts for much of the appointment time.
Most patients report that fluorescein angiography is not painful. The most uncomfortable part for most people is the needle stick when the intravenous line is placed, which is similar to having blood drawn. Once the line is in place, the dye injection itself may cause a brief warm sensation but is typically not painful. The photography portion of the test requires you to keep your eyes open and look in specific directions, which can cause mild eye fatigue but is not painful.
A regular comprehensive eye exam includes checking your vision, measuring your eye pressure, and examining the structures of your eye through dilated pupils. While your doctor can see the retina and its blood vessels during a dilated exam, this view shows only the surface appearance of the vessels at a single moment in time. It does not reveal how blood is actually flowing through those vessels or whether they are leaking.
Fluorescein angiography goes much further by providing a dynamic, real-time view of retinal blood flow. It reveals leaking vessels, areas of blockage, and abnormal vessel growth that may not be visible on a standard examination. Think of the difference as similar to looking at a road map versus watching traffic flow on that road in real time. Both are useful, but the real-time view provides information that the static map cannot.
Allergic reactions to fluorescein dye are uncommon, but your care team is fully prepared to manage them if they occur. Mild reactions, such as skin itching or hives, can typically be treated with antihistamine medications. More significant reactions, though rare, are managed with established medical protocols, and emergency equipment and medications are readily available in the office at all times.
Before your test, your care team will ask detailed questions about your allergy history. If you have had a previous reaction to fluorescein or have a history of multiple drug allergies, your doctor may recommend pretreatment with allergy medications before the test or may suggest an alternative diagnostic approach. Your safety is the top priority at every stage of the process.
Fluorescein dye is processed and eliminated by the kidneys, and in the small amounts used for this test, it is generally well tolerated by patients with normal kidney function. If you have known kidney disease or are on dialysis, it is important to let your care team know before the test so they can take this into consideration when planning your care.
Unlike some contrast agents used in CT scans or MRIs, fluorescein is not known to cause significant kidney damage. However, your care team will review your medical history and current health status before performing the test to ensure it is appropriate and safe for you as an individual patient.
The frequency of fluorescein angiography depends on your specific condition and how it is responding to treatment. Some patients may need the test only once to establish a diagnosis, while others with chronic conditions like diabetic retinopathy or wet macular degeneration may benefit from periodic repeat testing to monitor changes over time.
Your retinal specialist will recommend a follow-up schedule based on your individual needs. In many cases, other noninvasive tests like optical coherence tomography can be used for routine monitoring visits, with fluorescein angiography reserved for situations where the detailed vascular information it provides is specifically needed. Your care team will discuss the recommended monitoring plan with you and explain the reasoning behind each test that is recommended.